Join our CEO as he presents the latest progress on CUR-101 development at the 2nd BioCentury Grand Rounds Europe conference, being held from September 23-25, 2026 in Amsterdam.
📍 Track: Oncology
🗓 Thursday, Sep 25, 𝟮𝟬𝟮𝟲
⏰ 11:4𝟬 A𝗠 CET
📌 Otter Room, Hotel Okura, Amsterdam
Prof Philipp Jost, along with other leading experts in the field, authored an invited commemorative review in Cell by Cell Press — titled “𝘾𝙚𝙡𝙡 𝘿𝙚𝙖𝙩𝙝
We are excited to share that our Founder, 𝗣𝗿𝗼𝗳. 𝗗𝗿. Philipp Jost, will be presenting at the 𝗔𝗔𝗖𝗥 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟲 in San Diego this
We’re proud to share that 𝗣𝗿𝗼𝗳. 𝗗𝗿. Philipp Jost , Scientific Founder of Cycuria Therapeutics , is featured in Drug Target Review discussing innovative strategies
Our CEO & Co-Founder, Nisit Khandelwal, joined host Jim Cornall on the 𝗕𝗮𝘀𝗲-𝘁𝗼-𝗕𝗮𝘀𝗲 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗣𝗼𝗱𝗰𝗮𝘀𝘁 to discuss Cycuria Therapeutics’ approach to treating some of the
At Cycuria, we are dedicated to developing novel cytokine-based therapies to dramatically improve outcomes for patients living with cancer, offering hope where traditional treatments have fallen short.